California man gets eight years in prison for falsely labelling erectile dysfunction drug
pharmafile | August 20, 2019 | News story | Manufacturing and Production | FDA, erectile dysfunction, labellnig, pharma, tadalafil
A man from Walnut, California has been sentenced to eight years and four months in federal prison for illegally importing and selling $11 million worth of erectile dysfunction drugs which were falsely labelled as herbal remedies.
John Seil Lee, 41, was sentenced to eight years and four months, and fined more than $552,000 after pleading guilty to three counts of conspiracy, and to importing contraband and filing false tax returns for his businesses.
Lee’s companies, which imported drugs containing Tadalafil under names including, X Again, X Monster and Royal Master, sold the products across the United States without making customers aware that the products contained the drug. The products were also falsely labelled and falsely stated that no prescription was necessary.
Lee even continued to sell the drugs, under different names, after the FDA made announcements that the pills contained undeclared Tadalafil. “It’s obvious to me that this defendant has little or no respect for the law or the harm he caused numerous victims,” US District Judge Percy Anderson said.
Lee’s companies, KHK International Trade Enterprise and SHH World Trading Enterprises, were also each sentenced to five years’ probation and ordered to pay victims $115,484 in restitution.
Thirteen other companies and individuals also pleaded guilty to conspiring with Lee to sell the misbranded erectile dysfunction drugs. They are set to be sentenced next week.
Louis Goss
Related Content
Rethinking oncology trial endpoints with generalised pairwise comparisons
For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …
Alto Neuroscience’s schizophrenia treatment granted FDA Fast Track designation
Alto Neuroscience has announced that its investigational treatment for cognitive impairment associated with schizophrenia (CIAS) …
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …
